Targeting PDE3 with optimal doses and timing, enoximone prevents allergic inflammation in HDM-driven models of allergic airway inflammation. PDE3 inhibitors enoximone and milrinone can be used as a rescue drug in life-threatening bronchial asthma/acute severe asthma.